A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast
First Online: 11 August 2009 Received: 16 June 2008 Accepted: 13 July 2009 DOI:
Cite this article as: Okoshi, K., Saiga, T., Hisamori, S. et al. Breast Cancer (2012) 19: 360. doi:10.1007/s12282-009-0160-6 Abstract
We report a rare case of large-cell neuroendocrine carcinoma of the breast. A 63-year-old woman was admitted to our hospital with a firm mass in the right breast. Mammography revealed a high-density mass with specula, and ultrasonography showed a heterogeneous hypoechoic mass with irregular margin and posterior acoustical shadowing. She underwent breast-conserving surgery with axillary lymph node dissection. Histopathologically, the tumor consisted of large cells with polygonal and prominent nuclei and a small amount of eosinophilic cytoplasm, and these cells showed palisading arrangement with fibrous stroma. The tumor cells were positive for neuroendocrine markers such as NSE, synaptophysin, CD56 (NCAM), but not for chromogranin A. Interestingly, the tumor cells showed reactivity for cytokeratin 20 but not for cytokeratin 7. The immunostaining pattern is different from the usual adenocarcinoma of the breast. The patient received postoperative radiotherapy and was given adjuvant chemotherapy. She has remained disease-free for 44 months.
Keywords Large-cell neuroendocrine carcinoma Breast Cytokeratin 7 Cytokeratin 20 References
Tumours of the breast, neuroendocrine tumours. In: Tavassoli FA, Devilee P, editors. World health organization classification of tumours, pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003. pp 32–34.
Tsai WC, Yu JC, Lin CK, Hsieh CT. Primary alveolar-type large cell neuroendocrine carcinoma of the breast. Breast J. 2005;11:487.
Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962–72.
Monaghan P, Roberts JD. Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas. J Pathol. 1985;147:281–9.
Nesland JM, Holm R, Johannessen JV. A study of different markers for neuroendocrine differentiation in breast carcinomas. Pathol Res Pract. 1986;181:524–30.
Erikstein B, Nesland JM, Ottestad L, Lund E, Johannessen JV. Neuron specific enolase-positive breast carcinomas. Histol Histopathol. 1988;3:97–102.
Uccini S, Monardo F, Paradiso P, Masciangelo R, Marzullo A, Ruco LP, et al. Synaptophysin in human breast carcinomas. Histopathology. 1991;18:271–3.
Kitakata H, Yasumoto K, Sudo Y, Minato H, Takahashi Y. A case of primary small cell carcinoma of the breast. Breast Cancer. 2007;14:414–9.
Shaco-Levy R, Dyomin V, Kachko L, Sion-Vardy N, Geffen DB, Koretz M. Small cell carcinoma of the breast: case report. Eur J Gynaecol Oncol. 2007;28:142–4.
Mirza IA, Shahab N. Small cell carcinoma of the breast. Semin Oncol. 2007;34:64–6.
Bigotti G, Coli A, Butti A, del Vecchio M, Tartaglione R, Massi G. Primary small cell neuroendocrine carcinoma of the breast. J Exp Clin Cancer Res. 2004;23:691–6.
Adegbola T, Connolly CE, Mortimer G. Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature. J Clin Pathol. 2005;58:775–8.
Salman WD, Harrison JA, Howat AJ. Small-cell neuroendocrine carcinoma of the breast. J Clin Pathol. 2006;59:888.
Jochems L, Tjalma WA. Primary small cell neuroendocrine tumour of the breast. Eur J Obstet Gynecol Reprod Biol. 2004;115:231–3.
Shin SJ, DeLellis RA, Ying L, Rosen PP. Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients. Am J Surg Pathol. 2000;24:1231–8.
Samli B, Celik S, Evrensel T, Orhan B, Tasdelen I. Primary neuroendocrine small cell carcinoma of the breast. Arch Pathol Lab Med. 2000;124:296–8.
Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G. Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol. 2000;17:127–37.
Jiang SX, Kameya T, Shoji M, Dobashi Y, Shinada J, Yoshimura H. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases. Am J Surg Pathol. 1998;22:526–37.
Kato T, Terashima T, Tomida S, Yamaguchi T, Kawamura H, Kimura N, et al. Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon. Pathol Int. 2005;55:524–9.
Bernick PE, Klimstra DS, Shia J, Minsky B, Saltz L, Shi W, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47:163–9.
Susumu S, Matsuo S, Tsutsumi R, Sugiyama N, Azuma T, Yamaguchi S, et al. A case of large cell neuroendocrine carcinoma of the colon responding to FOLFOX. Acta Med Nagasaki. 2007;52:67–70.
Dundr P, Fischerova D, Povysil C, Cibula D. Primary pure large-cell neuroendocrine carcinoma of the ovary. Pathol Res Pract. 2008;204:133–7.
Alijo Serrano F, Sanchez-Mora N, Angel Arranz J, Hernandez C, Alvarez-Fernandez E. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Am J Clin Pathol. 2007;128:733–9.
Evans AJ, Al-Maghrabi J, Tsihlias J, Lajoie G, Sweet JM, Chapman WB. Primary large cell neuroendocrine carcinoma of the urinary bladder. Arch Pathol Lab Med. 2002;126:1229–32.
Lee KH, Ryu SB, Lee MC, Park CS, Juhng SW, Choi C. Primary large cell neuroendocrine carcinoma of the urinary bladder. Pathol Int. 2006;56(11):688–93.
Viacava P, Castagna M, Bevilacqua G. Absence of neuroendocrine cells in fetal and adult mammary glands. Are neuroendocrine breast tumours real neuroendocrine tumours? Breast. 1995;4:143–6.
CrossRef Copyright information
© The Japanese Breast Cancer Society 2009